PHI with Adult-onset Still's disease
How does this condition affect your private health insurance?
Adulte Form der Still-Krankheit (Adult-onset Still's Disease - AOSD) is a rare, systemic inflammatory disorder characterized by high spiking fevers, an evanescent salmon-pink rash, and arthralgia or arthritis. Other common manifestations include sore throat, lymphadenopathy, hepatosplenomegaly, and serositis. It is a diagnosis of exclusion, often mimicking severe infections or other autoimmune conditions. The exact cause is unknown, but involves an overactive immune response. AOSD can present as a single episode, recurrent flares, or chronic disease. Early diagnosis and aggressive treatment, including corticosteroids and sometimes biologics, are crucial to prevent complications like destructive joint damage and life-threatening macrophage activation syndrome.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to a few months, often requiring hospitalization for diagnosis and initial treatment.
Duration of Illness (Lifetime)
Can be a single monocyclic episode, but often polycyclic (recurrent flares over years) or chronic (persistent active disease over a lifetime).
Cost of Treatment (Initial)
Several thousand to tens of thousands of Euros/USD (hospitalization, diagnostics, initial medications like corticosteroids).
Cost of Treatment (Lifetime)
Tens of thousands to hundreds of thousands of Euros/USD, especially with long-term immunomodulatory drugs or biologic therapies.
Mortality Rate
Approximately 1-5% in general, but higher (up to 10-20%) if complicated by severe macrophage activation syndrome (MAS) or other organ damage.
Risk of Secondary Damages
Moderate to high. Chronic arthritis (20-40%), destructive joint damage (10-20%), potential organ involvement (e.g., liver, heart, lung), and life-threatening macrophage activation syndrome (5-10%).
Probability of Full Recovery
Variable. Around 30-50% achieve sustained remission without further relapses; others experience relapses or develop chronic disease.
Underlying Disease Risk
High probability (nearly 100%) that other serious conditions, such as severe infections (e.g., sepsis), malignancies (e.g., lymphoma), and other autoimmune diseases, must be rigorously ruled out to confirm the diagnosis of AOSD.